CLINICAL_TRIALS
trial_result
· 2015-04-29
Clinical Trial Update: Study of Atorvastatin Dose Dependent Reduction of Proteinuria [Phase 4]
Summary
A Phase 4 trial evaluating whether atorvastatin reduces proteinuria in chronic kidney disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Laval University | Conditions: Chronic Kidney Disease | Phase 4 | Status: COMPLETED